These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

924 related articles for article (PubMed ID: 9038509)

  • 1. The clinical significance of oncogene expression in subungual melanoma.
    Grover R; Grobbelaar AO; Hudson DA; Forder M; Wilson GD; Sanders R
    Br J Plast Surg; 1997 Jan; 50(1):15-9. PubMed ID: 9038509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of c-myc oncogene expression provides an accurate prognostic marker for acral lentiginous melanoma.
    Grover R; Chana J; Grobbelaar AO; Hudson DA; Forder M; Wilson GD; Sanders R
    Br J Plast Surg; 1999 Mar; 52(2):122-6. PubMed ID: 10434891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical significance of c-myc oncogene expression in melanomas of the scalp.
    Chana JS; Grover R; Wilson GD; Hudson DA; Forders M; Sanders R; Grobbelaar AO
    Br J Plast Surg; 1998 Apr; 51(3):191-4. PubMed ID: 9664877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of c-myc oncogene expression in uveal melanoma.
    Chana JS; Cree IA; Foss AJ; Hungerford JL; Wilson GD
    Melanoma Res; 1998 Apr; 8(2):139-44. PubMed ID: 9610866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of p16 tumour suppressor gene expression in acral lentiginous melanoma.
    Chana JS; Grover R; Wilson GD; Hudson DA; Forders M; Sanders R; Grobbelaar AO
    Br J Plast Surg; 2000 Jan; 53(1):46-50. PubMed ID: 10657449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of c-myc oncoprotein represents a new prognostic marker in cutaneous melanoma.
    Ross DA; Wilson GD
    Br J Surg; 1998 Jan; 85(1):46-51. PubMed ID: 9462382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of c-myc oncoprotein provides an independent prognostic marker for regional metastatic melanoma.
    Grover R; Ross DA; Wilson GD; Sanders R
    Br J Plast Surg; 1997 Oct; 50(7):478-82. PubMed ID: 9422944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic importance of c-myc oncogene expression in head and neck melanoma.
    Chana JS; Grover R; Wilson GD; Hudson DA; Forders M; Sanders R; Grobbelaar AO
    Ann Plast Surg; 2001 Aug; 47(2):172-7. PubMed ID: 11506326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma.
    Chana JS; Wilson GD; Cree IA; Alexander RA; Myatt N; Neale M; Foss AJ; Hungerford JL
    Br J Ophthalmol; 1999 Jan; 83(1):110-4. PubMed ID: 10209447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical management and prognostic factors in patients with subungual melanoma.
    Heaton KM; el-Naggar A; Ensign LG; Ross MI; Balch CM
    Ann Surg; 1994 Feb; 219(2):197-204. PubMed ID: 8129491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiology and prognosis of subungual melanoma].
    Paul E; Kleiner H; Bödeker RH
    Hautarzt; 1992 May; 43(5):286-90. PubMed ID: 1612918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The c-myc oncogene: use of a biological prognostic marker as a potential target for gene therapy in melanoma.
    Chana JS; Grover R; Tulley P; Lohrer H; Sanders R; Grobbelaar AO; Wilson GD
    Br J Plast Surg; 2002 Dec; 55(8):623-7. PubMed ID: 12550114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subungual melanoma. A clinicopathologic study of 16 Japanese cases.
    Takematsu H; Obata M; Tomita Y; Kato T; Takahashi M; Abe R
    Cancer; 1985 Jun; 55(11):2725-31. PubMed ID: 3995482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical aspects of subungual malignant melanomas. The Scottish Melanoma Group.
    Park KG; Blessing K; Kernohan NM
    Ann Surg; 1992 Dec; 216(6):692-5. PubMed ID: 1466623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of oncogene expression as an independent prognostic marker for primary melanoma.
    Grover R; Pacifico MD; Wilson GD; Sanders R
    Ann Plast Surg; 2003 Feb; 50(2):183-7. PubMed ID: 12567057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASO Author Reflections: Subungual Melanomas of the Hand Present Diagnostic and Therapeutic Challenges.
    Chakera AH; Thompson JF
    Ann Surg Oncol; 2019 Apr; 26(4):1044-1045. PubMed ID: 30719637
    [No Abstract]   [Full Text] [Related]  

  • 17. Bcl-2 expression in malignant melanoma and its prognostic significance.
    Grover R; Wilson GD
    Eur J Surg Oncol; 1996 Aug; 22(4):347-9. PubMed ID: 8783649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subungual Melanoma of the Hand.
    Chakera AH; Quinn MJ; Lo S; Drummond M; Haydu LE; Bond JS; Stretch JR; Saw RPM; Lee KJ; McCarthy WH; Scolyer RA; Thompson JF
    Ann Surg Oncol; 2019 Apr; 26(4):1035-1043. PubMed ID: 30565042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subungual melanoma: a study of 124 cases highlighting features of early lesions, potential pitfalls in diagnosis, and guidelines for histologic reporting.
    Tan KB; Moncrieff M; Thompson JF; McCarthy SW; Shaw HM; Quinn MJ; Li LX; Crotty KA; Stretch JR; Scolyer RA
    Am J Surg Pathol; 2007 Dec; 31(12):1902-12. PubMed ID: 18043047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapidly growing pigmented nail streak resulting in diffuse melanosis of the nail. A possible sign of subungual melanoma in situ.
    Kato T; Usuba Y; Takematsu H; Kumasaka N; Tanita Y; Hashimoto K; Tomita Y; Tagami H
    Cancer; 1989 Nov; 64(10):2191-7. PubMed ID: 2804909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.